The effects of semaglutide on depression, anxiety, and other psychiatric illnesses are currently being studied
The recommended dosages are based on the data from clinical trials for that specific use. For both types, higher doses may lead to negative side effects Increasing the dosage for both types of medications can come with negative side effects (nausea, vomiting, constipation, fatigue, loss of appetite and more)
The clinically warranted threshold for GLP-1 pharmacotherapy is BMI 27 with one weight-related comorbidity
Reconstituted semaglutide should be clear and colorless
The body converts pyridoxine into its active form, pyridoxal 5-phosphate (PLP), which then participates in the production of serotonin, dopamine, GABA, and norepinephrine